Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioRx Pharmaceuticals, Inc. is a vertically integrated pharmaceutical and cosmeceutical company and a wholly-owned subsidiary of Amexdrug Corporation (OTC: AXRX). Based in Commerce, California, the company specializes in the development, manufacturing, and distribution of over-the-counter (OTC) pharmaceuticals, innovative skincare products, and pharmacy supplies. Its flagship brand, Sponix, offers a diverse range of health and wellness products for skin, hair, and foot care, while its pharmaceutical division distributes generic and biosimilar medications such as Filgrastim and Docetaxel. BioRx Pharmaceuticals serves a national network of independent pharmacies, wholesalers, and healthcare providers, providing both therapeutic products and essential pharmacy operations supplies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioRX Pharmaceuticals.